InhaleRx Ltd: 2024 Annual Report

ASXMar 28 01:58 ET · Announcements

InhaleRx Executes Study Order for Phase Two Clinical Trial for Breakthrough Cancer Pain Management Drug Candidate

MT NewswiresMar 13 03:09 ET

InhaleRx Ltd: Preliminary Final Report

ASXFeb 26 01:23 ET · Announcements

InhaleRx Ltd Appoints Tony Fitzgerald as New Director

TipRanksFeb 6 00:07 ET

InhaleRx Procures $38.5m in Funding From Clendon Biotech to Progress Inhaled Therapies

Small CapsOct 17, 2024 23:01 ET

InhaleRx Surges 77% After Securing Nearly AU$39 Million for Clinical Trials; Shares Surge 59%

MT NewswiresOct 17, 2024 22:26 ET